Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Urs Fischer, MD, Inselspital, Bern University Hospital, Bern, Switzerland, discusses the uncertainty surrounding the safety of intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants (DOACs). Prof. Fischer highlights the ongoing DO-IT trial (NCT06571149) that aims to address this question. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.